skip banner navigation
National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
The SELECT Prostate Cancer Prevention Trial
    Updated: 08/03/2003



Introduction






NCI Materials






NCI Press Materials







NCI Cancer Information Service Fact Sheets






Other Materials






Current Clinical Trials



Page Options
Print This Page  Print This Page
Print This Document  Print This Document
View Entire Document  View Entire Document
E-Mail This Document  E-Mail This Document
Quick Links
Dictionary

Funding Opportunities

NCI Publications

NCI Calendar

Español
NCI Highlights
Chemo Extends Life in Advanced Prostate Cancer

Temozolomide Plus Radiation Helps Brain Cancer

Confirmed: Raloxifene Drops Risk of Breast Cancer

Bortezomib Delays Progression of Multiple Myeloma

Annual Report to the Nation

Past Highlights
Need Help?
Related Pages
Prostate Cancer Home Page
NCI's gateway for information about prostate cancer.
NCI Cancer Information Service Fact Sheets

Selenium and Vitamin E Cancer Prevention Trial (SELECT): Questions and Answers
A fact sheet that describes a clinical trial designed to determine if selenium and/or vitamin E can prevent prostate cancer.

Prostate Cancer Prevention Trial (PCPT): Questions and Answers
(Posted: 06/24/2003) - In the Prostate Cancer Prevention Trial (PCPT), 25 percent fewer men taking the drug finasteride developed prostate cancer than men not taking the drug. However, men who developed prostate cancer while taking finasteride were more likely to have high-grade cancers, which can spread quickly even if the tumors are small.

< Previous Section  |  Next Section >

skip footer navigation

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health FirstGov.gov